These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9641568)

  • 1. Preserved epitope-specific T cell activation by recombinant Bet v 1-MBP fusion proteins.
    van Neerven RJ; Sparholt SH; Schou C; Larsen JN
    Clin Exp Allergy; 1998 Apr; 28(4):423-33. PubMed ID: 9641568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of purified recombinant Bet v 1 with authentic N-terminus, cloned in fusion with maltose-binding protein.
    Spangfort MD; Ipsen H; Sparholt SH; Aasmul-Olsen S; Larsen MR; Mørtz E; Roepstorff P; Larsen JN
    Protein Expr Purif; 1996 Nov; 8(3):365-73. PubMed ID: 8936599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
    Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
    J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the T cell response to the major hazelnut allergen, Cor a 1.04: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergens.
    Bohle B; Radakovics A; Lüttkopf D; Jahn-Schmid B; Vieths S; Ebner C
    Clin Exp Allergy; 2005 Oct; 35(10):1392-9. PubMed ID: 16238801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells.
    Fritsch R; Bohle B; Vollmann U; Wiedermann U; Jahn-Schmid B; Krebitz M; Breiteneder H; Kraft D; Ebner C
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):679-86. PubMed ID: 9802379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12.
    Jahn-Schmid B; Siemann U; Zenker A; Bohle B; Messner P; Unger FM; Sleytr UB; Scheiner O; Kraft D; Ebner C
    Int Immunol; 1997 Dec; 9(12):1867-74. PubMed ID: 9466314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.
    Bohle B; Radakovics A; Jahn-Schmid B; Hoffmann-Sommergruber K; Fischer GF; Ebner C
    Eur J Immunol; 2003 Dec; 33(12):3303-10. PubMed ID: 14635038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four recombinant isoforms of Cor a 1, the major allergen of hazel pollen, show different reactivities with allergen-specific T-lymphocyte clones.
    Schenk S; Hoffmann-Sommergruber K; Breiteneder H; Ferreira F; Fischer G; Scheiner O; Kraft D; Ebner C
    Eur J Biochem; 1994 Sep; 224(2):717-22. PubMed ID: 7925389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell clones specific for Bet v I, the major birch pollen allergen, crossreact with the major allergens of hazel, Cor a I, and alder, Aln g I.
    Ebner C; Ferreira F; Hoffmann K; Hirschwehr R; Schenk S; Szépfalusi Z; Breiteneder H; Parronchi P; Romagnani S; Scheiner O
    Mol Immunol; 1993 Oct; 30(15):1323-9. PubMed ID: 7694084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides.
    Ebner C; Szépfalusi Z; Ferreira F; Jilek A; Valenta R; Parronchi P; Maggi E; Romagnani S; Scheiner O; Kraft D
    J Immunol; 1993 Feb; 150(3):1047-54. PubMed ID: 7678615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
    Ebner C; Schenk S; Najafian N; Siemann U; Steiner R; Fischer GW; Hoffmann K; Szépfalusi Z; Scheiner O; Kraft D
    J Immunol; 1995 Feb; 154(4):1932-40. PubMed ID: 7530747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a tagging system for subcellular localization of proteins encoded by open reading frames.
    Chuang CH; Hsu SC; Hsu CL; Hsu TC; Syu WJ
    J Biomed Sci; 2001; 8(2):170-5. PubMed ID: 11287747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of recombinant Bet v I, the major birch pollen allergen. Immunological equivalence to natural Bet v I.
    Ferreira FD; Hoffmann-Sommergruber K; Breiteneder H; Pettenburger K; Ebner C; Sommergruber W; Steiner R; Bohle B; Sperr WR; Valent P
    J Biol Chem; 1993 Sep; 268(26):19574-80. PubMed ID: 8366100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity.
    Bohle B; Breitwieser A; Zwölfer B; Jahn-Schmid B; Sára M; Sleytr UB; Ebner C
    J Immunol; 2004 Jun; 172(11):6642-8. PubMed ID: 15153479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossreactivity and T-cell epitope specificity of Bet v 1-specific T cells suggest the involvement of multiple isoallergens in sensitization to birch pollen.
    Sparholt SH; Larsen JN; Ipsen H; Schou C; van Neerven RJ
    Clin Exp Allergy; 1997 Aug; 27(8):932-41. PubMed ID: 9291292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
    Karamloo F; Schmitz N; Scheurer S; Foetisch K; Hoffmann A; Haustein D; Vieths S
    J Allergy Clin Immunol; 1999 Nov; 104(5):991-9. PubMed ID: 10550744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of Hor v 9. Conservation of a T-cell epitope among group IX pollen allergens and human VCAM and CD2.
    Astwood JD; Hill RD
    Adv Exp Med Biol; 1996; 409():269-77. PubMed ID: 9095254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells.
    Nagato T; Kobayashi H; Yanai M; Sato K; Aoki N; Oikawa K; Kimura S; Abe Y; Celis E; Harabuchi Y; Tateno M
    J Immunol; 2007 Jan; 178(2):1189-98. PubMed ID: 17202384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a highly promiscuous and an HLA allele-specific T-cell epitope in the birch major allergen Bet v 1: HLA restriction, epitope mapping and TCR sequence comparisons.
    Friedl-Hajek R; Spangfort MD; Schou C; Breiteneder H; Yssel H; Joost van Neerven RJ
    Clin Exp Allergy; 1999 Apr; 29(4):478-87. PubMed ID: 10202362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.